| http://www.w3.org/ns/prov#value | - But, Posner suggested that while the rituximab/immune globulin combination treatment is more expensive initially, a cost analysis comparing all of the costs, including hospitalizations, might find the combination treatment is the cheaper alternative in the long run.By Serena Gordon, HealthDay Reporter, October 26, 2006 Related Content
|
